Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for fatigue and functional impairment in chronic fatigue syndrome
NL-OMON23597Active, not recruiting
- Start
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of ondansetron in myalgic encephalomyelitis (ME). Primary endpoints: Fatigue severity, Functional impairment and 1 more. Started Jun 2002; status: active, not recruiting.
02
Drugs
ondansetron
03
Conditions
myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on NL-OMON23597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23597.